Healthcare provider profile · identity verified

Pal Lekaj, MD

Family Practice · KINGSTON, NY · NPI 1366407546

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	289	83
Omeprazole	Omeprazole	231	68
Rosuvastatin Calcium	Rosuvastatin Calcium	209	60
Atorvastatin Calcium	Atorvastatin Calcium	198	62
Levothyroxine Sodium	Levothyroxine Sodium	188	51
Alprazolam	Alprazolam	184	50
Gabapentin	Gabapentin	170	43
Metoprolol Succinate	Metoprolol Succinate	165	50
Losartan Potassium	Losartan Potassium	152	42
Tamsulosin Hcl	Tamsulosin Hcl	146	36
Carvedilol	Carvedilol	141	42
Lisinopril	Lisinopril	125	36
Metformin Hcl	Metformin Hcl	122	35
Oxycodone Hcl	Oxycodone Hcl	118	11
Trazodone Hcl	Trazodone Hcl	115	22
Pantoprazole Sodium	Pantoprazole Sodium	98	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	95	13
Escitalopram Oxalate	Escitalopram Oxalate	92	26
Albuterol Sulfate Hfa	Albuterol Sulfate	89	27
Eliquis	Apixaban	89	20
Furosemide	Furosemide	85	29
Jardiance	Empagliflozin	85	24
Trulicity	Dulaglutide	85	20
Potassium Chloride	Potassium Chloride	84	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	20
Meloxicam	Meloxicam	80	18
Allopurinol	Allopurinol	74	22
Zolpidem Tartrate	Zolpidem Tartrate	71	15
Fluoxetine Hcl	Fluoxetine Hcl	70	25
Hydrochlorothiazide	Hydrochlorothiazide	68	18
Clopidogrel	Clopidogrel Bisulfate	67	16
Prednisone	Prednisone	61	26
Finasteride	Finasteride	58	16
Simvastatin	Simvastatin	57	18
Sertraline Hcl	Sertraline Hcl	56	15
Famotidine	Famotidine	54	13
Duloxetine Hcl	Duloxetine Hcl	51	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	14
Bupropion Xl	Bupropion Hcl	48	12
Spironolactone	Spironolactone	47	12
Glipizide Er	Glipizide	46	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	15
Pregabalin	Pregabalin	44	11
Propranolol Hcl Er	Propranolol Hcl	44	suppressed
Tramadol Hcl	Tramadol Hcl	43	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	18
Azithromycin	Azithromycin	41	37
Ramipril	Ramipril	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	33
Fluticasone Propionate	Fluticasone Propionate	37	20
Lorazepam	Lorazepam	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Diazepam	Diazepam	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	28
Mounjaro	Tirzepatide	35	11
Metoprolol Tartrate	Metoprolol Tartrate	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Torsemide	Torsemide	31	12
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	23
Janumet	Sitagliptin Phos/Metformin Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Nystatin	Nystatin	26	20
Tradjenta	Linagliptin	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	19
Glipizide	Glipizide	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	14
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Liothyronine Sodium	Liothyronine Sodium	21	suppressed
Ozempic	Semaglutide	21	suppressed
Dutasteride	Dutasteride	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	12
Synthroid	Levothyroxine Sodium	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Linzess	Linaclotide	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	13
Ezetimibe	Ezetimibe	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Levemir Flexpen	Insulin Detemir	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pen Needles	Pen Needle, Diabetic	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error